Switching to pills will be a game changer for many users that are not confortable using weekly injectables
GLP-1 receptor agonists, such as semaglutide (sold under the brand name Ozempic or Wegovy) and tirzepatide (brand name Mounjaro or Zepbound), are medications originally developed for diabetes and now approved for chronic weight management at specific doses
They did not exhibit any hepatocellular injury, inflammatory cells, or necrosis
its positioned as a potential add-on technology across multiple existing therapies, rather than a direct competitor to any single drug
Thyroid C-Cell Tumors: In mice and rats, semaglutide (the active ingredient in Wegovy and Ozempic) caused an increase in thyroid C-cell tumors, including medullary thyroid carcinoma (MTC)
Candidal infections under the breast or the pannus are common and can be treated with topical antifungals